Target intelligence / Profile preview

RNA, U6 small nuclear 321, pseudogene (RNU6-321P)

Target
RNU6-321P
Molecular classification
Other (non-coding RNA, pseudogene)
01

Overview

RNU6-321P is a pseudogene member of the U6 small nuclear RNA gene family. The U6 snRNA is a highly conserved and essential component of the spliceosome required for pre-mRNA splicing in eukaryotes[1][5]. However, the RNU6-321P locus itself is annotated as a pseudogene, indicating it is a non-functional, non-coding remnant derived from retrotransposition or duplication of a functional U6 gene[2][4]. The human genome contains many U6-derived pseudogenes, which are considered largely unexpressed and do not produce functional snRNA molecules[4]. There is no evidence that RNU6-321P is transcribed or plays a role in cellular biology, pathology, or as a therapeutic target. Key points: - The “target” is a non-functional pseudogene rather than a protein, enzyme, receptor, or functional RNA. - It is NOT a receptor, enzyme, or otherwise therapeutically relevant molecular target. - No approved drugs or experimental inhibitors are known for this locus. - Functional U6 snRNA is clinically important for splicing, but RNU6-321P does not contribute to that function. If the intention was to find a therapeutically actionable target, this pseudogene entry is not suitable and would yield “false” for the is_target property. No errors in naming or identification are apparent, but the target is irrelevant as a therapeutic entity.

Other names
RNU6-321PRNA, U6 small nuclear 321, pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

None documented (as it is a pseudogene; functional U6 snRNA is essential for RNA splicing, but pseudogenes are typically not functional)
04

Disease associations

None specific to the pseudogene (pseudogenes might have rare regulatory effects, but no established disease roles for RNU6-321P)

Beyond the preview

Go deeper on RNA, U6 small nuclear 321, pseudogene (RNU6-321P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 321, pseudogene (RNU6-321P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call